Table 6:
Monthly Per-Person Costs Used in the Economic Model—Reference Case
| Mean ($) | SEa | Source | |
|---|---|---|---|
| Phototherapy | |||
| Home | |||
| Initial cost: cost of deviceb | 3,912.34 | 499.02 | Manufacturer79,c |
| Monthly cost: cost of bulb replacementb | 24.86 | 3.17 | Manufacturer79,c |
| Outpatient clinic | |||
| Monthly cost | 19.63 | 2.50 | Schedule of Benefits35 |
| Physiciand | |||
| Home NB-UVB | 9.66 | 1.23 | Schedule of Benefits35 |
| Outpatient clinic NB-UVB | 7.84 | 1.00 | Schedule of Benefits35 |
| On topical therapy only | 9.66 | 1.23 | Schedule of Benefits35 |
| Topical Treatment | |||
| Betamethasone valerate, 0.05% | 51.33 | 6.55 | Mikhael et al, 200958 |
Abbreviations: CI, confidence interval; NB-UVB, narrowband ultraviolet B phototherapy; SE, standard error.
a
Assumed 95% CI as ± 25% of the mean, and SE was calculated accordingly.
b
Cost included 13% sales tax and 10% administrative cost.
c
Daavlin representative (S. Borton, phone communication, December 12, 2018).
d
Calculated as the annual cost divided by 12.